טוען...
New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
BACKGROUND: Glucocorticosteroid is used for patients with primary nephrotic syndrome. This study aims to identify and validate that biomarkers can be used to predict steroid resistance. METHODS: Our study contained two stages, discovery and validation stage. In discovery stage, we enrolled 51 minima...
שמור ב:
| הוצא לאור ב: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7257237/ https://ncbi.nlm.nih.gov/pubmed/32514258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09282-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|